Libra Infusions Limited announced unaudited earnings results for the third quarter and nine months ended March 31, 2017. The company's EPS was BDT 4.10 for January-March, 2017 as against BDT 2.95 for January-March, 2016. The company's EPS was BDT 4.88 for July, 2016-March, 2017 as against BDT 5.64 for July, 2015-March, 2016. NOCFPS was BDT 6.66 for July, 2016-March, 2017 as against BDT 35.21 for July, 2015-March, 2016. NAV per share was BDT 1,580.47 as on March 31, 2017 and BDT 1,577.14 as on March 31, 2016.